Search - tctmd.com

Displaying 121 - 140 of 873

Sort: Relevancy | Date

News Daily News

Top Structural Heart News of 2023

Todd Neale

January 02, 2024

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

Shelley Wood

January 01, 2024

News Daily News

Top Heart Rhythm News of 2023

Todd Neale

December 26, 2023

News Daily News

Top Policy and Practice News for Cardiologists in 2023

Caitlin E. Cox

December 20, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

News Daily News

Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO

Todd Neale

November 29, 2023

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Shelley Wood

November 27, 2023

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

Presenter: Fabio Enrique Posas

October 26, 2023

Presentation TCT 2023

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

Presenter: Janarthanan Sathananthan

October 25, 2023

Presentation TCT 2023

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

Presenter: Sze Jia Ng

October 25, 2023

Presentation TCT 2023

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

Presenter: Steven Yakubov

October 25, 2023

Presentation TCT 2023

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

Presenter: Guilherme Attizzani

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2023

TCT 32: Predicting Commissural Alignment for the Evolut Valve Using 3D Modeling and Printing

Presenter: Osama Elkhateeb

October 25, 2023

Presentation TCT 2023

TCT 663: The Evolution of Artificial Intelligence (AI) Capabilities in the Peripheral Endovascular Field

Presenter: Anthony Pham

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Advertisement

Top Structural Heart News of 2023

The Biggest News of 2023: TCTMD’s Top 10

Top Heart Rhythm News of 2023

Top Policy and Practice News for Cardiologists in 2023

TCTMD’s Top 10 Most Popular Stories for November 2023

Outcomes Suffer When Device-Related Thrombus Persists or Recurs After LAAO

Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCTMD’s Top 10 Most Popular Stories for October 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

TCT 906: Leaflet Thrombosis in a patient with Severe, Bicuspid Aortic Valve Stenosis and Severely Depressed LVEF: Acute Leaflet Thrombosis Less than 24 Hours After Evolut R Implantation

TCT 386: Sapien 3 in Degenerated Calcified Evolut: Assessing Hydrodynamic Function and Leaflet Kinematics After Redo-TAVR

TCT 954: High Risk Left Main Stenting through EVOLUT Valve with Impella Support from Axillary Access

Optimizing Outcomes With Self-Expanding Valves: The OPTIMIZE PRO Study and Evolut PRO Plus and FX Valves

TCT 248: Assessment of Coronary Cannulation, Commissure and Coronary Alignment post TAVR with the New Supra-Annular, Self-Expanding Evolut FX System

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 32: Predicting Commissural Alignment for the Evolut Valve Using 3D Modeling and Printing

TCT 663: The Evolution of Artificial Intelligence (AI) Capabilities in the Peripheral Endovascular Field

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content